Think1st, respectfully, with the dilution for acquisitions...
I'm taking my chances that the GRST CEO has a plan that will eliminate dilution and move forward with acquisition plans that will be non-dilutive such as using non-dilutive preferred shares either already existing or newly created like how some other companies do it. I'm guessing that he is smart enough to understand how that works.
How many OTCs use dilutive funding ...I'd say nearly all of them. How many OTCs have a real facility in operation with multiple employees and a verifiable business...I'd say few.
There's your answer.
Dilutive funding is a necessary evil in the OTC...just gotta hope your DD shows that they have a real business and expanding to eventually have enough top and bottom line to support shareholder growth despite the dilution.